They were also more likely to use insulin or multiple oral agents.<h4>Conclusion</h4>About one-quarter of patients with T2DM had DN, and half received treatment, mostly α-lipoic acid monotherapy. The gene discussed is INS; the disease is type 2 diabetes mellitus.